Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints

Area of Science:

• Hematology
• Molecular Cytogenetics
• Oncology

Background:

• The t(8;21)(q22;q22) translocation is a frequent karyotypic abnormality in acute myeloid leukemia (AML), occurring in approximately 15% of cases.
• This translocation leads to the formation of the RUNX1/CBFA2T1 fusion gene, crucial in AML pathogenesis.
• While translocations are well-studied, insertion events (ins(8;21) and ins(21;8)) resulting in the same fusion gene have been observed but lack detailed breakpoint characterization.

Purpose of the Study:

• To provide a detailed molecular cytogenetic characterization of insertion events that generate the RUNX1/CBFA2T1 fusion gene in acute myeloid leukemia.
• To analyze the breakpoints and sizes of inserted elements in cases of ins(8;21) and ins(21;8).

Main Methods:

• FISH (Fluorescence In Situ Hybridization) experiments were employed.
• Bacterial artificial chromosome (BAC) and P1 artificial chromosome (PAC) probes were utilized for detailed analysis.
• Molecular cytogenetic characterization was performed on six AML cases with insertion events.

Main Results:

• Six insertion events (ins(8;21) and ins(21;8)) were identified among 82 AML cases with the RUNX1/CBFA2T1 fusion, representing 7.3% of the cohort.
• Detailed molecular cytogenetic analysis revealed variable breakpoints in these insertion events.
• The size of the inserted elements varied significantly, ranging from 2.4 to 44 Mb.

Conclusions:

• Insertion events are an alternative mechanism for generating the RUNX1/CBFA2T1 fusion gene in AML, in addition to the canonical t(8;21) translocation.
• The variability in breakpoints and insert sizes highlights the complex nature of these genomic rearrangements.
• Further characterization of insertion events provides a more comprehensive understanding of AML cytogenetics and potential therapeutic targets.